Sensitization to fungi often leads to a severe form of asthma that is particularly difficult to manage clinically, resulting in increased morbidity and hospitalizations in these patients. Although B lymphocytes might exacerbate asthma symptoms through the production of IgE, these cells might also be important in the protective response against inhaled fungi. Through cytokine release and T-cell interactions, these lymphocytes might also influence the development and maintenance of airway wall fibrosis. J H 2/2 mice lack the JH gene for the heavy chain component of antibodies, which is critical for B-cell function and survival. These animals have facilitated the elucidation of the role of B lymphocytes in a number of immune responses; however, J H 2/2 mice have not been used to study fungal allergy. In this study, we examined the role of B lymphocytes using an Aspergillus fumigatus murine fungal aeroallergen model that mimics human airway disease that is triggered by environmental fungal exposure. We compared disease progression in sensitized wild-type BALB/c and J H 2/2 mice that were exposed to repeated fungal exposure and found no differences in airway hyperresponsiveness, overall pulmonary inflammation or collagen deposition around the large airways. However, the levels of the Th2-type cytokines IL-4 and IL-13 were significantly attenuated in the airways of J H 2/2 mice relative to the BALB/c controls. By contrast, levels of the inflammatory cytokines IL-17A and IL-6 were significantly elevated in the J H 2/2 animals, and there was significantly more robust airway eosinophilia and neutrophilia than in control animals. Taken together, these findings demonstrate that B lymphocytes help to regulate granulocytic responses to fungal exposure in the pulmonary compartment.
INTRODUCTION
Allergic asthma is a chronic inflammatory disease of the lungwith increasing prevalence in the United States and other industrialized countries. [1] [2] [3] This disease is characterized by pulmonary inflammation, eosinophilia and mucus hypersecretion, leading to impaired lung function. [4] [5] [6] There is no cure for asthma, but therapeutic options for allergic asthma include corticosteroids, antihistamines, eicosanoid inhibitors, and monoclonal anti-IgE. The latter has the potential to provide substantial benefit but its use is limited by its cost. The responsible use of the currently available therapies and the development of novel therapies depend on an adequate understanding of the mechanisms that contribute to the development of allergic asthma.
Sensitization to fungi with the production of IgE and/or colonization by fungal species often signals a disease course that is particularly difficult to treat and that results in chronic changes in the architecture of the lung, causing long-term morbidity. 2, 7, 8 The hallmarks of chronic airway inflammation in patients with severe or persistent fungal asthma include the accumulation of activated eosinophils, 9-11 neutrophils, 12, 13 lymphocytes 12, 14 and ECM components. 15, 16 To recapitulate many of the acute and chronic features of clinical fungal asthma, we developed an Aspergillus fumigatus experimental model in which sensitization of mice with fungal extracts is followed by allergy challenge with inhaled Aspergillus conidia. 17 The model results in IgE production, leukocytic pulmonary inflammation, and pronounced peribronchial fibrosis, all of which are exaggerated upon subsequent repeated exposure to inhaled conidia. 10, 14, 17, 18 Recruitment of eosinophils and B cells is a particularly interesting component of the inflammatory response following fungal challenge, as the roles of these cells in the context of pulmonary responses to fungi have not been investigated.
B cells in all stages of activation and differentiation are detected in increased numbers in the blood and bronchial mucosa of clinical patients undergoing an asthma attack. 4, 19, 20 Our research and others' have tracked the influx of B cells into the allergic lungs. 4, 14, 20 Until now, the role of B cells in allergic asthma has been thought to be limited to the production of Abs, which mediate mast cell degranulation. 21, 22 The pathophysiological involvement of allergen-specific Abs is supported by the successful use of anti-IgE therapies. [23] [24] [25] Although allergen-specific antibodies are recognized as contributing factors in the immunopathology of aberrant responses against innocuous allergens, such as pollen or animal dander, 26 these factors have also been implicated in the successful clearance of fungi from the airways. 27, 28 Therefore, in the current study, we examined the contribution of B cells to the development and maintenance of the allergic phenotype in lungs that were sensitized to and challenged with fungal extracts and conidia, respectively.
Using an A. fumigatus murine inhalation model to mimic human fungal asthma, 14, 17 we compared the effects of repeated A. fumigatus inhalation in BALB/c wild-type controls and J H 2/2 animals. The absence of JH gene did not alter the pulmonary pathology that results from inhalation of A. fumigatus in allergic animals; airway hyperresponsiveness (AHR), pulmonary inflammation, epithelial changes and collagen deposition in J H 2/2 mice were equivalent to those in wild-type controls. However, J H 2/2 mice had significantly more neutrophils and eosinophils in their airways than wild-type mice. The levels of the Th2-type cytokines IL-4 and IL-13 were significantly attenuated in the bronchoalveolar lavage (BAL) fluid of J H 2/2 mice relative to BALB/c controls. However, levels of the inflammatory cytokines IL-6 and IL-17A were significantly elevated in J H 2/2 mice after fungal challenge compared with BALB/c controls, suggesting that B cells have a role in the allergic lung and that IL-17A and IL-6 are involved in responses to fungal allergens.
MATERIALS AND METHODS

Ethics statement
All experiments were performed in accordance with the Office of Laboratory Animal Welfare guidelines and were approved by the North Dakota State University Institutional Animal Care and Use Committee, Fargo, ND, USA.
Experimental animals BALB/c mice (6-9 weeks of age) were obtained from Jackson Laboratory (Bar Harbor, ME, USA) and J H 2/2 mice (6-9 weeks of age) were obtained from Taconic Laboratory (Hudson, NY, USA). The J H -targeted Mutation Mouse Model carries a targeted deletion of the J H locus, such that the mice are homozygous for the absence of all four J H gene segments. 29 As a result, the cells cannot produce a complete, recombined version of the variable region of the antibody heavy chain. Cells of the B lineage in J H -targeted mutant mice are drastically altered in both developmental progression and cell quantity by the absence of J H genes. This mouse model provides a null background for the antibody heavy chain J H gene segment, which makes it suitable for investigating the mechanisms of B-cell differentiation and antibody production. 29 The animals were housed on Alpha-dri paper bedding (Shepherd Specialty Papers, Watertown, TN, USA) in microfilter-topped cages (Ancare, Bellmore, NY, USA) in a specific pathogen-free facility with ad libitum access to food and water.
Allergen sensitization and challenge using an airborne delivery system The animals were sensitized as previously described. 30 Briefly, BALB/c or J H 2/2 mice were sensitized using 10 mg of A. fumigatus antigen extract (Greer Laboratories, Lenoir, NC, USA) in 0.1 ml phosphate-buffered saline (PBS) mixed with 0.1 ml of Imject Alum (Pierce, Rockford, IL, USA), which was injected both subcutaneously (0.1 ml) and intraperitoneally (0.1 ml). After 2 weeks, the mice were given three intranasal 20-mg doses of A. fumigatus antigen in 20 ml of PBS at 1-week intervals. One week after the final dose, the animals were challenged by being exposed to a nasal aerosol of live A. fumigatus conidia as the first inhalational challenge (IH1). 17 For the inhalational challenge (IH), each anesthetized mouse was placed supine with its nose in an inoculation port to inhale the live fungal conidia for 10 min. This challenge was performed once at week 8 (IH2) and repeated at week 10 (IH3). The mice were separated into groups of five for analysis on day 3 after the second inhalational challenge [D3 (IH2)], day 3 after the third inhalational challenge [D3 (IH3)] and day 28 after the third inhalational challenge [D28 (IH3)]. 31 The experimental protocol is depicted in Figure 1 . Age-matched BALB/c or J H 2/2 mice that were neither sensitized nor challenged were used as naive controls.
Airway hyperresponsiveness measurement
The mice were anesthetized using sodium pentobarbital (100 mg/kg of mouse body weight; Butler, Columbus, OH, USA), intubated and ventilated using a Harvard pump ventilator (Harvard Apparatus, Reno, NV, USA) to assess allergic airway responses. Restrained plethysmography (Buxco, Troy, NY, USA) was used to assess AHR. Before obtaining the readings, the system was first calibrated and the stroke volume was set at 225, with a rate of 150 strokes/min. The baseline airway resistance was measured for each animal before an intravenous injection of acetyl-b-methacholine (210 mg/kg) was administered to determine AHR at each time point.
Serum and BAL sample collection Approximately 500 ml of blood was collected from each mouse via ocular bleed and centrifuged at 13000 g for 10 min to obtain B lymphocytes in fungal asthma S Ghosh et al serum. BAL was performed on five mice per group using 1.0 ml of sterile PBS. The serum and BAL fluid were stored at 220 uC until use. The BAL fluid from each animal was centrifuged at 2000 g for 5 min to separate the cells from the fluid. The cells were resuspended in 200 ml of PBS, cytospun (Shandon Scientific, Runcorn, UK) onto glass microscope slides, and counted after staining with Quik-Dip differential stain (Mercedes Medical, Sarasota, FL, USA). The mean number of each cell type was determined by morphometric analysis. The results were reported as the means of each cell type per highpowered field (hpf, 31000).
Tissue harvest and histological analysis
The left lobes of the lungs were inflated ex vivo and fixed in 10% neutral-buffered formalin overnight before embedding in paraffin. The lungs were cut longitudinally across the coronal plane in 5-mm sections and stained with hematoxylin and eosin (H&E), Gomori's trichrome stain (Richard-Allan Scientific, Kalamazoo, MI, USA),or periodic acid Schiff's (PAS) stain (Richard-Allan Scientific). Slides were coded and the inflammation (H&E) in each lung section was evaluated by three blinded pathologists to the study design. Scoring for each section was evaluated on a scale of 0 to 4 with increments of 0.5.
Gomori's trichrome-stained histological sections were used to assess subepithelial collagen deposition in BALB/c and J H 2/2 mice as previously described. 17 For each sample, at least 50 discrete points were measured at 50-mm intervals along the largest lateral bronchiolar branch visible on the histological section (the second or third lateral branch). A perpendicular line was drawn from the basement membrane through the full thickness of the collagen layer located immediately below. The mean collagen thickness was reported for each sample, and the mean of the means was reported for each group. PAS-stained tissue sections were used to visualize mucusproducing goblet cells, which were counted along ten randomly selected 100-mm segments of basement membrane for each mouse lung. The ratio of goblet cells to total epithelial cells per 1.0 mm of basement membrane was used to determine the percentage of goblet cells at each time point.
Real-time quantitative PCR (qRT-PCR) Total RNA was extracted from the lung tissues of naive and allergic animals using a standardized TRIzol method based on phenol extraction (Invitrogen, Carlsbad, CA, USA). Total RNA was measured using a NanoDrop (Wilmington, DE, USA). The A260/280 ratios were between 1.90 and 2.1 for all samples. One microgram of RNA from each time point was subjected to DNase I (Promega, Madison, WI, USA) treatment and was used to generate cDNA using iScript reverse transcription mix for qRT-PCR (Cat # 170-8840) from Bio-Rad according to the manufacturer's instructions (Bio-Rad, Hercules, CA, USA). The real-time reactions contained 5 ml of cDNA template (1 : 25 dilution) with 10 ml of a 23 SsoAdvanced Universal SYBR Green Supermix (Cat # 172-5270; Bio-Rad), 1 ml of 203 primers (Bio-Rad) and 4 ml of nuclease-free H 2 O (Qiagen, Valencia, CA, USA) in a final volume of 20 ml. The transcript expression was measured in duplicate using qRT-PCR. The MUC5AC mRNA levels were determined by qRT-PCR. The transcript-specific MUC5AC primer (Cat # 100-25636) was purchased from Bio-Rad. Mouse hypoxanthine-guanine phosphoribosyl transferase (HPRT) was used as an internal control, and the relative transcript abundance was normalized to the amount of hypoxanthine-guanine phosphoribosyl transferase for the qRT-PCR data. All samples were analyzed for dissociation curves and melting temperatures to confirm single amplification species. The mean fold changes were calculated as the average of the duplicate measurements for each gene. The qRT-PCR reaction was conducted using a CFX96 real-time system with the following parameters: 2 min at 95 uC to denature the cDNA and to activate the Taq polymerase, followed by 40 cycles of 5 s at 95 uC and 30 s at 60 uC. The control reactions for all amplicons were conducted with nuclease-free water in the absence of reverse transcriptase to ensure o6 cycle thresholds compared with reactions in the presence of reverse transcriptase. This control would verify f1.6% genomic DNA contamination in the reactions according to the manufacturer's description. The relative fold difference was calculated using the 2 DDC T method.
Measurement of chemokine levels in lung tissue supernatants
The frozen right lobe (after BAL) was homogenized in 600 ml DMEM containing Complete Mini Protease Inhibitor Cocktail (Roche, Indianapolis, IN, USA). The lung homogenates were centrifuged at 9000 g for 10 min at 4 uC. The eotaxin (CCL11) levels were measured in the supernatants of lung homogenates using a quantitative calorimetric platinum sandwich ELISA kit purchased from eBioscience (San Diego, CA, USA) according to the manufacturer's instructions. Similarly, the levels of fumigatus murine model of allergic asthma. The mice were initially sensitized using immunizations and intranasal inoculations of fungal antigens. After 1 week, the mice were exposed to live A. fumigatus conidia as the first inhalational exposure (IH1). Two weeks after the first inhalational exposure, the mice were exposed to a second inhalational with live A. fumigatus conidia (IH2). Two weeks after the second inhalational exposure, the mice were exposed to a third and final inhalational with live A. fumigatus conidia (IH3). Groups of animals were assessed at various time points after inhalational exposure (by convention, the time points are named according to the day after the inhalational challenge, i.e., D3 (IH2), D3 (IH3) and D28 (IH3)). Naive animals were used as negative controls.
mouse keratinocyte-derived cytokine (KC), also known as CXCL1, were measured in the supernatants of the lung homogenates using an ELISA kit purchased from R&D Systems (Minneapolis, MN, USA). The sensitivity of these assays was 31.3 pg/ml for CCL11 and 15.6 pg/ml for KC.
Antibody and cytokine ELISA IgA, IgE, IgG1, IgG2a, IL-4, IL-6, IL-12, IL-13 and IL-17A levels were measured using ELISA kits purchased from eBioscience according to the manufacturer's instructions.
Statistical analysis
Data from allergic BALB/c wild-type and J H 2/2 animals were compared with each other and with their respective naive controls at each time point. The results were expressed as the means6standard error of the mean (s.e.m.). The data were evaluated using GraphPad Prism software (San Diego, CA, USA) and an unpaired, Student's two-tailed t-test with Welch's correction to determine statistical significance. A P value of ,0.05, indicated with an asterisk, was considered statistically significant, and the hash symbol indicates significant differences between BALB/c and J H 2/2 mice at a given time point.
RESULTS
Airborne fungal challenge results in AHR in J H 2/2 mice after sensitization to A. fumigatus In the current study, the AHR of both murine groups (i.e., BALB/c and J H 2/2 animals) was monitored in naive mice and at days D3 (IH2), D3 (IH3) and D28 (IH3) after conidia inhalation ( Figure 2 ). The airway response measurements from all animals were averaged to determine the baseline for AHR prior to methacholine challenge (Figure 2 , dotted line, 1.0160.02 cmH 2 O/ ml/s). The airway responses measured before methacholine challenge were low and reproducible from group to group. At day 3 after the second or third conidia challenges (Figure 2) , AHR was significantly increased in both BALB/c and J H 2/2 mice compared with the naive controls. However, there was no difference in the AHR values of J H 2/2 animals compared with BALB/c wild-type controls. By day 28 after the third conidia challenge, the AHR values for both groups had returned to baseline, irrespective of the presence or absence of the J H gene.
Leukocytes are recruited to allergic airways after fungal conidia challenge in J H 2/2 mice Leukocyte recruitment in the lungs of allergic mice was evaluated using H&E-stained lung tissue sections and morphometric analysis of BAL cells. Neither naive BALB/c mice nor naive J H Next, we performed morphometric analyses using monocyte/macrophage lineage cells, neutrophils, eosinophils and lymphocytes to estimate the relative makeup of the cellular inflammation and to monitor leukocyte egress into the airway lumen ( Figure 4 ). In naive BALB/c and J H 2/2 animals, alveolar macrophages were the dominant cell type present (Figure 4a ). In wild-type BALB/c controls, most cell populations (macrophages, neutrophils, eosinophils and lymphocytes) were elevated in the BAL fluid at 3 days after the second conidia challenge (Figure 4 ). This result is consistent with a previous study of the total number of leukocytes in the BAL fluid after two challenges. 17 However, at 3 days after the second conidia challenge, J H 2/2 mice had significantly lower numbers of eosinophils (,83% fewer eosinophils) and lymphocytes (,71% fewer lymphocytes) in the BAL fluid compared with the BALB/c mice ( Figure 4) . Following the third inhalational exposure, macrophages, neutrophils, eosinophils and lymphocytes were the prominent cell types in the BAL compartment of both BALB/c and J H 2/2 mice, emphasizing the polarization of the immune response in favor of allergy after multiple inhalations of conidia. However, at this time point, the J H 2/2 mice had significantly higher numbers of neutrophils (,200%) and eosinophils (,400%) in the BAL compartment compared with the wild-type BALB/c controls (Figure 4b and c) . At 28 days after the third conidia challenge, macrophages were again the major cellular component of the BAL compartment in both the murine groups (Figure 4a ).
Fungal conidia inhalation significantly increases goblet cell metaplasia in allergic J H 2/2 mice Goblet cells were assessed through the examination of histological sections to calculate the percentage of PAS-positive mice. A baseline response was obtained prior to methacholine challenge (mean value of 1.0160.02 cmH 2 O/ml/s is indicated by the dotted line). AHR was increased following allergen challenge, and the trend was similar in both groups throughout the course of the study. The data were analyzed using an unpaired, Student's two-tailed t-test with Welch's correction. All values are expressed as the means6s.e.m. n55-10 mice/group, *P,0.05 was considered statistically significant compared with the respective naive controls. The data shown are representative of two independent experiments. AHR, airway hyperresponsiveness. Figure 4 Effect of A. fumigatus conidia inhalation on inflammatory leukocytes in the allergic lung. Airway inflammation was marked by the presence of macrophages (a), neutrophils (b), eosinophils (c) and lymphocytes (d) in naive, allergic BALB/c and J H 2/2 mice. The data were analyzed using an unpaired, Student's two-tailed t-test with Welch's correction. All values are expressed as the means6s.e.m. n55-10 mice/ group, *P,0.05 was considered statistically significant compared with the respective naive controls.
# P,0.05 was considered statistically significant when J H 2/2 mice were compared with BALB/c animals. The data shown are representative of two independent experiments.
B lymphocytes in fungal asthma S Ghosh et al group (about 40%-50% of total) was approximately twice that of J H 2/2 animals (,20% of total) after two or three fungal challenges ( Figure 5 ). At 28 days after the third conidia challenge, goblet cells represented only approximately 15% of the cells lining the airway epithelium of BALB/c mice, whereas goblet cells in J H 2/2 animals represented approximately 20 % of the cells lining the epithelium (Figure 5e ). Given the difference in mucus production between BALB/c and J H 2/2 allergic animals, we used qRT-PCR to examine the changes in MUC5AC mRNA expression in the lungs of allergen-challenged BALB/c and J H 2/2 mice. The results showed that MUC5AC mRNA was ,40-fold higher in the lungs of BALB/ c mice than in J H 2/2 mice 3 days after the second conidia challenge [D3 (IH2)] (Figure 5f ). Similarly, MUC5AC mRNA was ,80-fold higher in the lungs of BALB/c mice than in J H 2/2 mice3 days after the third conidia challenge [D3 (IH3)] (Figure 5f ). At 28 days after the third aerosol challenge [D28 (IH3)], MUC5AC mRNA expression had returned to the levels seen in naive mice in both groups.
Fungal conidia inhalation significantly increases collagen deposition in allergic J H
2/2 mice to levels equivalent to those in BALB/c animals As a hallmark of airway wall remodeling, collagen deposition around the large airways was assessed by measuring the peribronchial collagen thickness. Little collagen was observed around the large airways in naive wild-type or knockout mice (Figure 6a, b and i) . On day 3 after the second conidia inhalation, both BALB/c and J H 2/2 mice showed increased and equivalent collagen deposition around the large airways (Figure 6c , d and i), and this increase in peribronchial collagen was also observed on day 3 after the third inhalation (Figure 6e, f and i) . Collagen accumulation in the peribronchial space of allergic BALB/c or J H 2/2 animals remained significantly increased 28 days after the third inhalation compared with naive animals (Figure 6g, h and i) . The collagen accumulation did not diminish over the time course of this study, consistent with previous observations obtained in various mouse strains and at various time points using this model.
17,31,32
Fungal inhalation increases IL-4, IL-13 and IL-12 levels in the airways of allergic BALB/c mice but not J H 2/2 mice The development of allergic lung disease is mediated by cytokines including the Th2-associated cytokines IL-4, IL-5 and IL-13. To assess the impact of B cells on the production of Th1 and Th2 cytokines in the lungs of allergic mice, the levels of a panel of Th1 and Th2 cytokines were measured in BAL fluid from sensitized and challenged BALB/c and J H 2/2 mice using ELISA. (Figure 7 ), whereas this increased production was less marked in the airways of J H 2/2 mice after conidia challenge (Figure 7) .The reduction in Th2 cytokines in BAL from J H 2/2 mice after conidia challenge was .75%, and these mice exhibited baseline cytokine levels. Similarly, the reduction in the Th1 cytokine IL-12 in BAL from J H 2/2 mice was approximately 50%. Together, these results demonstrate that B cells promote the production of cytokines, particularly IL-4, IL-13 and IL-12.
Fungal inhalation increases eotaxin and KC in the lungs of allergic BALB/c and J H 2/2 mice Eotaxin and KC have long been associated with eosinophilia and neutrophilia in mouse models of allergic asthma, 33-36 so we assessed the levels of these chemokines in the fungal model to determine whether these compounds could be responsible for the increased granulocytic inflammation seen in the absence of B cells. Following the second and third conidia challenges, eotaxin (Figure 8a ) and KC (Figure 8b ) levels were significantly elevated in the lungs of BALB/c and J H 2/2 mice, consistent with increased numbers of eosinophils and neutrophils in the BAL compartment. However, there was no difference in the levels of eotaxin and KC between the BALB/c and J H 2/2 groups. Moreover, eotaxin and KC levels were undetectable in the BAL fluid of naive BALB/c and J H 2/2 mice at these time points. (data not shown).
Fungal inhalation increases IL-6 and IL-17A in the airways of allergic J H 2/2 but not BALB/c mice As there was no difference in the levels of lung eotaxin and KC between BALB/c and J H 2/2 mice, we thought that other factors Figure 6 Effect of A. fumigatus conidia inhalation on peribronchial collagen thickness. Gomori's trichrome stain was used to visualize subepithelial collagen deposition in histological sections from BALB/c and J H 2/2 mice. Approximately 50 discrete points were measured at 50-mm intervals along the largest lateral bronchiolar branch visible on the histological section (L2 or L3). A perpendicular line was drawn from the basement membrane through the full thickness of the collagen layer located immediately below. The mean collagen thickness was reported for each sample. (a-i) The collagen distribution (stained with Gomori's trichrome stain, green color) around the large airways is shown in the lung sections, representing the 14-week time course of A. fumigatus exposure. The data were analyzed using an unpaired, Student's twotailed t-test with Welch's correction. All values are expressed as the means6s.e.m. n55 mice/group, *P,0.05 was considered statistically significant compared with the respective naive controls. The data shown are representative of two independent experiments. 2/2 mice. The data were analyzed using an unpaired, Student's two-tailed t-test with Welch's correction. All values are expressed as the means6s.e.m. n55 mice/group, *P,0.05 was considered statistically significant compared with the respective naive controls.
# P,0.05 was considered statistically significant when J H 2/2 mice were compared with BALB/c animals. BAL, bronchoalveolar lavage. might be involved in mediating granulocytic influx in the absence of B lymphocytes. IL-6 and IL-17A have been associated with granulocyte recruitment in other allergy models, [37] [38] [39] [40] [41] so we assessed the levels of these cytokines in the fungal model to determine whether they could be responsible for the increased granulocytic inflammation seen in the absence of B cells. After the third conidia challenge, the levels of IL-6 ( Figure 9a ) and IL-17A ( Figure 9b ) were significantly higher in the BAL fluid of J H 2/2 mice than in the BAL fluid of BALB/c mice, consistent with increased numbers of neutrophils and eosinophils in the BAL compartment of the J H 2/2 mice at D3 (IH3). IL-6 and IL-17A were undetectable in the BAL fluid of BALB/c mice at this time point (Figure 9a and b) . DISCUSSION B lymphocyte infiltration of tissues occurs in a variety of chronic diseases, including allergic lung disease, although the contribution of this phenomenon to asthma remains unclear. In the current study, we provide evidence that B lymphocytes are involved in regulating granulocytic inflammation in a murine model of fungal allergic asthma. In the absence of B cells, we demonstrated a potential mechanism by which levels of IL-6 and IL-17A are elevated in the airways of sensitized animals that are challenged with inhaled fungal conidia; this cytokine production corresponds to pronounced granulocytic inflammation, compared with wild-type sensitized/challenged animals.
Chronic allergic lung disease is associated with sustained inflammatory cell infiltration into the lungs. Previous studies of B cells in OVA-induced allergic disease have shown that B cells are not involved in overall inflammation, Th2 responses, eosinophilia, or AHR in allergic disease. 42 Other studies using repeated aerosol exposure to OVA have established that B celldeficient mice show reduced lung inflammation and mucus compared with allergic parental strain control animals. 43 Consistent with previous studies, we observed that J H 2/2 mice produce less mucus than wild-type mice after fungal challenge. Although AHR, total lung tissue inflammation, and excessive collagen deposition were comparable to those seen in BALB/c controls following chronic allergen challenge, J H 2/2 animals had significantly more granulocytic inflammation, indicating that B lymphocytes are involved in regulating fungus-associated inflammation. In addition, Th2 cytokine production was significantly attenuated in the absence of B cells. This apparent discrepancy with previously published studies suggesting that B 2/2 mice. The data were analyzed using an unpaired, Student's twotailed t-test with Welch's correction. All values are expressed as the means6s.e.m. n55 mice/group, *P,0.05 was considered statistically significant compared with the respective naive controls.
# P,0.05 was considered statistically significant when J H 2/2 mice were compared with BALB/c animals. BAL, bronchoalveolar lavage.
lymphocytes do not contribute to allergic inflammation or Th2 responses 42 might reflect the route of the pathogenic/allergenic challenge and the type of antigen used. This discrepancy might also indicate that immune responses are altered by different antigenic stimuli, suggesting that B-cell activation has a different role in response to fungal pathogens/allergens.
In the lungs, a number of factors might influence the relative importance of B lymphocytes versus other antigen presenting cells (APCs) in the development of T-cell responses and cytokine production. These roles might include anatomical location, receptor specificity and antigen uptake and processing. There is considerable evidence that dendritic cells (DCs) are the most efficient APC for stimulating naive T cells. 4, 44, 45 However, other studies have demonstrated that B cells in the lymph nodes can present antigens at levels similar to those of dendritic cells, which are primarily considered to be the main APCs of the immune system. Other studies have indicated cooperation between DCs and B lymphocytes, with DCs handing off antigens to B lymphocytes. 4, 46 Such a cooperative scenario might occur in the parenchyma of the allergic lung. 4, 47 Consistent with previous studies, we have demonstrated an influx of B lymphocytes into the allergic lung. 4, 14 In the context of chronic allergic lung disease, a continuing supply of antigen, coupled with the dramatic influx of B lymphocytes to the lungs, might favor B lymphocytes over other APCs and thereby influence Tcell responses. This effect might also explain why Th2 responses are reduced in the absence of B lymphocytes in J H 2/2 mice. B-cell antigen presentation is becoming increasingly recognized as an important contributor to disease pathogenesis. 4, [48] [49] [50] Previous studies using mMT mice in an asthma model have suggested that B cells help to mediate Th2 responses. Using a cockroach antigen model, Lindell et al. 4 reported a 50% decrease in Th2 cytokines in the absence of B lymphocytes. Similarly, in the current study, the production of Th2 cytokines was significantly attenuated (similar to naive levels) in J H 2/2 mice. However, we observed a reduction (.75%) in the production of Th2 cytokines in the absence of B cells. This apparent contradiction might reflect the presence of B1 cells in mMT mice as previously reported. 32 Thus, it is reasonable to speculate that, under physiological allergic conditions, B lymphocytes might have a significant role in mediating Th2 cytokine production. However, the results presented in this study do not mechanistically mimic the effect of B-cell Ag presentation on Th2 responses. Future studies will address this issue.
B cells might have a regulatory role in allergic asthma 4, 50, 51 or indirectly influence the T-cell response through the alteration of DC function and/or lymph node organization, modifying the resulting phenotype of the response. 48, 49, 52 In the current study, we demonstrate an expanded role for B lymphocytes in regulating inflammation in the allergic lung. Interestingly, J H 2/2 mice had significantly more granulocytic inflammation than did the control group at three days after the third exposure to the live fungus. This observation suggests that the increase in granulocytic inflammation might be regulated by B cells. It is possible that in the absence of B lymphocytes the development/ survival of Tregs or inducible Tregs is impaired, potentially reflecting the more robust neutrophilic and eosinophilic inflammation in these mice. [53] [54] [55] Further studies are needed to address this issue.
How then can we explain the increased eosinophilia and neutrophilia observed in the J H 2/2 mice under attenuated Th2 responses? Previous studies have shown that eotaxin and KC contribute to eosinophil and neutrophil recruitment in allergic asthma. 33, 35, 36 Therefore, we examined the relationship between eotaxin/KC chemokine levels and granulocytic inflammation in both BALB/c and J H 2/2 mice. Although eotaxin/KC levels in the lung were elevated after conidia challenge in both groups, there was no significant difference between the BALB/c and J H 2/2 mice, suggesting that other factors might be involved in mediating increased granulocytic inflammation in the absence of B lymphocytes. Recent studies have revealed that Th17 cells, a new T-helper cell lineage that produces IL-17 and related cytokines might have important roles in the development of pulmonary inflammation and AHR. IL-6 also promotes inflammation and pulmonary fibrosis, 41, 56 suggesting that the 'Th2 theory' is probably inadequate to explain the diverse forms of asthma in humans and the various inflammatory responses observed in animal models of allergic asthma. 12, 57, 58 In recent years, a number of research groups have demonstrated a more direct role for IL-17 in exacerbating eosinophilia and neutrophilia. 12, [58] [59] [60] Similarly, the neutralization of IL-6 has been associated with decreased inflammation in allergic mice, and this phenomenon occurs in conjunction with IL-17A, indicating that IL-6 regulates IL-17A production in models of lung injury. 41 Consistent with these observations, we also observed an increased IL-17 and IL-6 response in the absence of B lymphocytes in J H 2/2 mice. Thus, we hypothesized that, in the absence of B cells, the induction of IL-6/IL-17A axis results in increased granulocytic inflammation in the airways of J H 2/2 mice compared with the BALB/c mice, in which IL-6/IL-17A production was significantly attenuated. This observation might also suggest that B cells regulate inflammation in fungal asthma by limiting IL-6 and IL-17A production during allergic lung disease because the production of IL-17A and IL-6 is low in control BALB/c mice. This result is consistent with a recent study 58 demonstrating a role for IL-17 in driving pulmonary eosinophilia, suggesting that this cytokine is involved in the initiation of the inflammatory response.
Some studies have speculated that B lymphocytes are involved in regulating IL-17 production by T cells. 4, 58 In the current study, we did not detect IL-17 production by T cells using intracellular cytokine staining of lung lymphocytes in J H 2/2 mice, suggesting that the expression of lung IL-17A in this model is not T cell-derived (data not shown). Although the cellular source of IL-17A in J H 2/2 mice during A. fumigatus infection remains unknown, recent studies suggest that macrophages or innate lymphoid cells might contribute to early IL-17 production in allergic asthma. 38, 57, 59, 61 This observation highlights the need for further research to clarify the role of IL-17A in fungal asthma.
In conclusion, these findings demonstrate that B lymphocytes are important in regulating inflammation in a chronic A. fumigatus-mediated lung disease model. Moreover, these findings might have important implications for understanding normal B cell activation in health and disease.
